BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8140566)

  • 1. [Cardiotoxicity of 5-fluorouracil. Clinical picture of 4 cases and a prevention proposal].
    Bourgeois H; Perault MC; Raud-Raynier P; Favrelière S; Daban A; Vandel B
    Therapie; 1993; 48(3):255-8. PubMed ID: 8140566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
    de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
    Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity of 5-fluorouracil: coronary spasm? Apropos of 2 cases with normal coronarography].
    Cristofini P; Desnos M; Guenot O; Funck F; Hagege A; Trotoux J; Guerot C
    Ann Med Interne (Paris); 1989; 140(1):9-13. PubMed ID: 2660665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity induced by 5-fluorouracil. Review of the literature].
    Blázquez Encinar JC; Martín Jiménez M; Díaz-Rubio García E; Almenarez J
    Rev Clin Esp; 1989 Mar; 184(5):249-51. PubMed ID: 2672149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
    Porta C; Moroni M; Ferrari S; Nastasi G
    Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angina attack caused by 5-fluorouracil infusion--report of a case and review of the literature].
    Yokoyama T; Hosoya Y; Aoki T; Saito S; Nihei Y; Kobayashi N; Shoji M; Saito Y; Nagai H
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1805-8. PubMed ID: 12402434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic cardiotoxicity associated with 5-fluorouracil.
    Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
    Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of 5-fluorouracil. Personal cases and review of the literature].
    Segalini G; Labianca R; Beretta GD; Borsotti E; Calasso F; Carini L; De Ceglia S; Rocca A
    G Ital Cardiol; 1987 Sep; 17(9):781-5. PubMed ID: 3319758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
    Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
    Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute cardiotoxicity from 5-fluorouracil: un underestimated toxicity].
    Bertolini A; Fiumanò M; Muffatti A; Pedroncelli S; Doria A; Codazzi G; Giustiniani S; Scarinci A; Redaelli G
    Minerva Cardioangiol; 1999; 47(7-8):269-73. PubMed ID: 10582438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac toxicity of fluoro-uracil. Typical and atypical aspects. Apropos of 8 cases].
    Ferrari E; Taillan B; Tibi T; Darmon JP; Gibelin P; Chichmanian RM; Dujardin P; Morand P
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):191-5. PubMed ID: 1642435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-Fluorouracil (5-FU) cardiotoxicity. Evaluation by dynamic ECG].
    Pellegrini F; Di Noto G; Ansuini G; Pisani E; Russo P; Luzi Fedeli S; Torresi U; Guidi F; Cellerino R
    Recenti Prog Med; 1986 Jan; 77(1):46-9. PubMed ID: 2422710
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does 5-fluorouracil cardiotoxicity exist? Presentation of 2 cases with acute manifestations and clinico-instrumental study of 12 cases in chronic treatment with 5-fluorouracil].
    Pinelli G; Lusa AM; Salvarani R; Di Pasquale G; Roncuzzi R; Coluccini M
    Minerva Cardioangiol; 1984 Sep; 32(9):627-30. PubMed ID: 6514209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possible cardiotoxicity induced by orally administered fluoropyrimidines].
    Camps C; Godes M; Soler JJ
    An Med Interna; 1990 Oct; 7(10):525-7. PubMed ID: 2104099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.